| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.0008 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | 0.44 | 0.002 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.092 | 0.003 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | 0.46 | 0.005 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.006 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | 0.099 | 0.006 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.096 | 0.006 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.007 |